Tag : TYPE 2 DIABETES
Continuous glucose monitoring has become an essential tool in modern diabetes management, providing insight into glucose patterns and variability not captured by HbA1c alone. Current evidence indicates that glycemic assessment must extend beyond HbA1c, particularly for individuals with T2D who face an elevated risk of microvascular and cardiometabolic complications.1 Evolving clinical guidance supports a multidimensional approach to glycemia, positioning CGM as a critical instrument for therapy selection, titration, treatment intensification, and individualized lifestyle modification.1 At ATTD-ASIA 2025, Dr. Daphne Gardner from Singapore General Hospital highlighted the practical benefits of CGM in T2D management, emphasizing its role in detecting glycemic excursions, guiding therapy adjustments, and supporting patient-centered care.1
Type 2 diabetes (T2D) is a chronic disorder that can lead to a high disease burden and repeated hospital admissions due to its ability to facilitate a multitude of subsequent morbidities.1 Conventional studies often focus on investigating the risk of time-to-first events in T2D patients, giving limi
According to the American Diabetes Association (ADA)/ European Association for the Study of Diabetes (EASD) guideline, a patient-centered approach to type 2 diabetes (T2D) management should be adopted with the goal of not only preventing complications but also optimizing patients’ quality of life.1 To achieve these goals, factors that affect health-related quality of life (HRQoL) such as social determinants of health, psychosocial well-being, and health behaviors are key considerations in glycemic management strategies for patients with T2D.1 At the EASD Annual Meeting 2023, Professor Chan, Chung-Ngor Juliana from the Department of Medicine and Therapeutics, The Chinese University of Hong Kong presented the results of a cross-sectional analysis of HRQoL in patients with T2D treated with oral glucose-lowering drugs (OGLDs) who were enrolled in the Joint Asia Diabetes Evaluation (JADE) Register. In a subsequent interview with Omnihealth Practice, Prof. Chan shared further insights on the application of the JADE® Program, shedding light on the dynamics between glycemic management strategies and patients’ HRQoL.
